AIRS Medical’s SwiftMR® Gains FDA Approval for Deep Learning Integration in Imaging Solutions
SwiftMR® by AIRS Medical Obtains FDA Clearance for Enhanced Imaging
In a significant development for the medical imaging community, AIRS Medical has announced that its platform SwiftMR®, an FDA 510(k) approved MRI image enhancement solution, has received the green light to function in conjunction with original equipment manufacturers’ (OEM) deep learning (DL) reconstruction solutions. This strategic move promises to redefine imaging processes, introducing efficiency and effectiveness in MRI diagnostics.
Enhancing Efficiency with SwiftMR®
SwiftMR® operates by integrating with existing deep learning solutions from various OEMs. This dual functionality allows it to work in tandem with current technologies, aiding in further reducing MRI scanning times, which is crucial in busy clinical environments. For instance, in an imaging facility equipped with GE 3T scanners utilizing AIR Recon DL, routine brain scans that previously took 15 minutes could now be completed in just 9 minutes, shaving off valuable time without compromising quality.
Furthermore, when an OEM’s deep learning solution does not cover a specific pulse sequence, SwiftMR® extends its capabilities, enhancing image quality through AI and decreasing scan durations for various pulse sequences across the body’s anatomy. This comprehensive coverage has been in clinical use since 2023 and is now officially recognized by the FDA.
Clinical Insights and Benefits
Jina Park, AIRS Medical's Strategy Director, pointed out, “The difference between a 15-minute and a 10-minute exam can translate to a 30 to 20-minute slot for scheduling appointments.” Such advancements not only optimize operation flows but also improve patient throughput, a crucial aspect in healthcare settings.
Meanwhile, Woojin Jung, the Product Manager at AIRS Medical, elaborated on the past year’s rigorous training and testing of the SwiftMR® platform. “We specifically tailored SwiftMR® on DL-processed images, ensuring its alignment with OEM standards. The FDA's approval attests to its quality and provides our clients confidence in deploying SwiftMR® alongside existing OEM solutions.”
Existing Deployments and Future Prospects
SwiftMR®, in conjunction with OEM deep learning systems, is already available for adoption by imaging centers and hospitals aiming to accelerate examinations and optimize appointment scheduling. Interested parties can learn more and request demonstrations by visiting AIRS Medical’s website at airsmed.com.
Continuing the Legacy of Innovation in Imaging
SwiftMR® continues to build on AIRS Medical’s commitment to enhancing MRI technology through deep learning. As a platform capable of reducing examination times by up to 50%, it is currently operational in over 1,700 imaging centers across more than 40 countries. This achievement underscores AIRS Medical’s dedication to providing groundbreaking solutions to the global medical community.
About AIRS Medical
AIRS Medical is a global leader in AI medical imaging, aiming to transform MRI practices through deep learning technologies. Their platforms, including SwiftMR® and SwiftSight®, are widely adopted in top healthcare systems and imaging networks worldwide. For further details, visit airsmed.com.
Disclaimer: While SwiftMR® aims to reduce scanning times and improve imaging quality, specific duration claims are site-dependent and may vary based on scanner models, field intensity, imaging protocols, and site configurations. Please refer to airsmed.com for comprehensive usage guidelines and performance data.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.